The peripheral intervention market — the commercial ecosystem for endovascular devices, tools, and systems treating peripheral arterial disease, venous disease, aortic aneurysms, carotid artery disease, and visceral vascular conditions beyond cardiac indications — represents a large and commercially diverse cardiovascular device market, with the Peripheral Intervention Market...
Chronic limb-threatening ischemia (CLTI) — the evolution of the CLI terminology toward CLTI emphasizing its chronic nature and incorporating the full spectrum from rest pain through tissue loss — represents the paradigm shift in peripheral vascular intervention that is reshaping treatment approaches, clinical trial design, and commercial market development, with the Peripheral...